Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults

March 2007

There's a lot of buzz about Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults.

You'll see it on the shelves this summer...costing about $2 a day.

Alli is half the strength of Xenical...but expect similar efficacy and side effects. Doubling the dose doesn't add much benefit.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

eRx Now, the new free e-prescribing system
Infectious Diseases recommendations for treating community-acquired pneumonia in adults
Women's Health whether the newer low-dose, combination oral contraceptive pills are less effective
Supplements People are being told to take MORE vitamin D and LESS calcium
Cardiology Coreg CR, a new extended-release carvedilol
Cardiology new antihypertensive called Tekturna, the first direct renin inhibitor
Gastroenterology Lialda (lee-AL-duh) is the first ONCE-daily oral mesalamine for ulcerative colitis
Gastroenterology both a proton pump inhibitor PLUS an H2-blocker for GERD
Pediatrics news reports of bowel obstruction in infants vaccinated with RotaTeq
OTC Products Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults
OTC Products OTC brand name product extensions continue to cause confusion
Kidney Disease minimize the risk of nephropathy due to the contrast dyes used for diagnostic tests
if their MEDS can cause weight gain